Acquisitions Expansion Arbor Biotechnologies has been actively acquiring companies like Serendipity Biosciences, indicating potential synergies and market expansion opportunities for additional products or services.
Partnerships for Growth Through partnerships with industry leaders like Allogene Therapeutics, 4DMT, and Ginkgo Bioworks, Arbor Biotechnologies is leveraging collaborations for innovation and product development in genetic medicines and gene editing technologies.
Top Talent Recruitment Arbor Biotechnologies demonstrates a commitment to growth by strategically appointing industry veterans like R. Nolan Townsend to the Board of Directors and Ajim Tamboli as Chief Financial Officer, which may signal further expansion and business development initiatives.
Diverse Tech Stack With a diverse tech stack including Python, C++, and tools like Canva and Microsoft Suite, Arbor Biotechnologies showcases technological capabilities that can be leveraged for customized solutions and tailored offerings to potential clients.
Strategic Funding Position With total funding amounting to $215M and revenue in the range of $10M - 50M, Arbor Biotechnologies is in a strong financial position to invest in growth opportunities, making it an appealing partner for collaborations and service acquisitions.
Arbor Biotechnologies uses 8 technology products and services including Canva, Microsoft Excel, Microsoft Word, and more. Explore Arbor Biotechnologies's tech stack below.
| Arbor Biotechnologies Email Formats | Percentage |
| FLast@arbor.bio | 98% |
| Last@arbor.bio | 1% |
| LF@arbor.bio | 1% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Arbor Bio is a next-generation gene editing company focused on discovering and developing potentially curative genomic medicines, with the most extensive toolbox of proprietary genomic editors in the industry. We have the unique ability to work backward from disease pathology and choose the optimal editors or combination of editors for the disease in question.
Company Overview
Media & News
Funding & FinancialsArbor Biotechnologies has raised a total of $215M of funding over 2 rounds. Their latest funding round was raised on Nov 09, 2021 in the amount of $215M.
Arbor Biotechnologies's revenue is in the range of $10M$50M
Funding & FinancialsArbor Biotechnologies has raised a total of $215M of funding over 2 rounds. Their latest funding round was raised on Nov 09, 2021 in the amount of $215M.
Arbor Biotechnologies's revenue is in the range of $10M$50M
Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.
1-888-653-2347 
support@leadiq.com